A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/09/2006	WO2006118871A2 Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis
11/09/2006	WO2006118821A2 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound,that provides fatty acid metabolism and glycolysis inhibition
11/09/2006	WO2006118749A1 Thia-tetraazaacenaphthylene kinase inhibitors
11/09/2006	WO2006118665A2 Method for reducing levels of disease associated proteins
11/09/2006	WO2006118630A2 Phosphoinositide modulation for the treatment of alzheimer's disease
11/09/2006	WO2006118605A2 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
11/09/2006	WO2006118598A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
11/09/2006	WO2006118562A1 Purgative composition and uses thereof
11/09/2006	WO2006118534A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux
11/09/2006	WO2006118370A1 Composition for improving constipation comprising sugar and sugar alcohols
11/09/2006	WO2006118351A1 Mono-lysine salts of azole compounds
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006118329A1 Stable emulsion composition
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006118313A1 Novel polypeptide and use thereof
11/09/2006	WO2006118307A1 Therapeutic agent for pain
11/09/2006	WO2006118299A1 Gpcr inhibitor
11/09/2006	WO2006118278A1 Temperature-sensitive liposome and temperature-sensitive drug release system
11/09/2006	WO2006118268A1 Therapeutic agent for chronic obstructive pulmonary disease
11/09/2006	WO2006118265A1 Composition containing antidementia agent
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118246A1 Transdermal absorption accelerator
11/09/2006	WO2006118231A1 Cyanopyridine derivative and use thereof as medicine
11/09/2006	WO2006118212A1 Agent for preventing and treating pancreatitis
11/09/2006	WO2006118210A1 Method of preventing dihydropyridine compound from degradation
11/09/2006	WO2006118173A1 Trenadermal absorption preparation
11/09/2006	WO2006118170A1 Therapeutic agent for corneal disease
11/09/2006	WO2006118169A1 Antiasthmatic drug comprising pgd2 receptor antagonist and leukotriene receptor antagonist
11/09/2006	WO2006118137A1 Granular preparation containing biguanide compound
11/09/2006	WO2006118127A1 Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism
11/09/2006	WO2006118087A1 Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
11/09/2006	WO2006118079A1 Antiaging agnet for skin
11/09/2006	WO2006118074A1 Composition for inducing sleep containing vegetable essential oil component as the active component, transdermal absorption type sleep inducing agent containing the composition and method of producing the same
11/09/2006	WO2006118017A1 Stabilized composition
11/09/2006	WO2006117995A1 Therapeutic agent for loss of scalp hair
11/09/2006	WO2006117977A1 Process for production of carbostyril compound
11/09/2006	WO2006117885A1 External preparation for skin
11/09/2006	WO2006117762A2 Antimicrobial agents
11/09/2006	WO2006117760A1 Adrenergic receptor antagonists
11/09/2006	WO2006117754A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
11/09/2006	WO2006117743A1 Substituted aromatic compounds as antidiabetic agents
11/09/2006	WO2006117696A2 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
11/09/2006	WO2006117684A1 Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds
11/09/2006	WO2006117677A1 Androgen modulators
11/09/2006	WO2006117675A1 Fatty acid-benzenediol derivatives and methods of making and using thereof
11/09/2006	WO2006117670A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
11/09/2006	WO2006117668A1 Fatty acid analogues, i.e. dha derivatives for uses as a medicament
11/09/2006	WO2006117666A2 Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery
11/09/2006	WO2006117664A1 New dha derivatives and their use as medicaments
11/09/2006	WO2006117660A2 Method for treating cancer, coronary, inflammatory and macular disease, combining the modulation of zinc- and/or copper dependent proteins
11/09/2006	WO2006117657A1 Triazolone derivatives as anti-inflammatory agents
11/09/2006	WO2006117653A1 Azole-based phosphodiesterase inhibitors
11/09/2006	WO2006117616A1 Polymorphic form i of lumefantrine and processes for its preparation
11/09/2006	WO2006117614A1 Process for the preparation of pramipexole and new anhydrous forms of its dihydrochloride
11/09/2006	WO2006117611A1 Histamine h3-recept0r ligands and their therapeutic application
11/09/2006	WO2006117609A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands
11/09/2006	WO2006117608A1 Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist
11/09/2006	WO2006117600A2 Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies
11/09/2006	WO2006117592A1 Methods of modulating nuclear receptors
11/09/2006	WO2006117570A1 Quinoline derivatives as kinase enzyme inhibitors
11/09/2006	WO2006117560A1 Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer
11/09/2006	WO2006117552A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006	WO2006117549A1 Enzyme inhibitors
11/09/2006	WO2006117548A1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity
11/09/2006	WO2006117523A1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
11/09/2006	WO2006117521A1 Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase
11/09/2006	WO2006117404A2 Topical use of radical capturing substances for antipyretic treatment
11/09/2006	WO2006117400A2 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors
11/09/2006	WO2006117371A1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
11/09/2006	WO2006117370A1 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
11/09/2006	WO2006117368A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
11/09/2006	WO2006117360A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((R)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
11/09/2006	WO2006117359A1 CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
11/09/2006	WO2006117353A1 Inhalation device containing plural doses of a pharmaceutical composition
11/09/2006	WO2006117316A1 Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
11/09/2006	WO2006117315A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protecctive activity
11/09/2006	WO2006117314A2 Novel piperidin- substituted indoles and their use as ccr-3 modulators
11/09/2006	WO2006117306A1 Heterocyclic antiviral compounds
11/09/2006	WO2006117305A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	WO2006117304A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
11/09/2006	WO2006117300A2 Crystalline forms of tiotropium bromide
11/09/2006	WO2006117221A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders
11/09/2006	WO2006117220A2 Method of administering a cationic liposomal preparation comprising paclitaxel
11/09/2006	WO2006117217A2 Novel use of spiegelmers
11/09/2006	WO2006117197A1 Antitumoral tetrahydro-pyrimidines
11/09/2006	WO2006117185A1 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
11/09/2006	WO2006117183A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/09/2006	WO2006117165A2 Means and methods for the treatment of head injuries and stroke
11/09/2006	WO2006117164A1 Nutritional supplement or functional food comprising oil combination
11/09/2006	WO2006117139A2 Solid transdermal therapeutic system comprising uv absorber
11/09/2006	WO2006117075A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006	WO2006117029A1 Use of polylysine in combination with either green tea or olive extracts or both for use against halitosis
11/09/2006	WO2006117023A1 Dihydropyridine derivatives
11/09/2006	WO2006116953A1 A method for the preparation of tegaserod and slected salts thereof
11/09/2006	WO2006116897A1 Diterpenes from euphorbia kansui and their use
11/09/2006	WO2006116874A1 Compositions and methods for modulating dopamine neurotransmission
11/09/2006	WO2006116873A1 Diagnosis and treatment of endometriosis
11/09/2006	WO2006116867A1 Genemap of the human genes associated with crohn's disease
11/09/2006	WO2006116862A1 Method for inhibiting er stress-induced apoptosis

1 ... 4012 4013 4014 4015 4016 4017 4018 4019 4020 4021 4022 4023 4024 4025 4026 4027 4028 4029 4030 4031 4032 ... 7860